Michael SchwartzProcess Development Strategy at BenchlingSpeaker
Profile
Michael Schwartz is an experienced operator at the intersection of life sciences and digital technology. He currently focuses on process development applications at Benchling, bringing the R&D Cloud to global biotechnology innovators across the world. Michael was formerly at Salesforce as Senior Director, Life Sciences focused on pharmaceutical strategy. His early career includes co-founding of Fluxion Biosciences (acq: Cell Micro) and being an early employee at Advanced Stent Technologies (acq: BSX). Michael received his M.S. in Biomedical engineering from Columbia University and B.S. in Bioengineering from U.C. Berkeley.
Agenda Sessions
Unlocking efficiency: how digitalization and AI are redefining biopharmaceutical process development
, 1:00pmView Session